(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | 1 | |
Other cash income from operating activities | ---- | --1 |
Cash paid | -18.36%-745.26K | -629.65K |
Payments to suppliers for goods and services | -18.36%-745.26K | ---629.65K |
Direct interest received | 6,655.61%13.85K | --205 |
Operating cash flow | -16.20%-731.41K | ---629.45K |
Investing cash flow | ||
Cash flow from continuing investing activities | 70.43%-263.85K | -892.15K |
Capital expenditure reported | 70.28%-263.85K | ---887.64K |
Net PPE purchase and sale | ---- | ---4.51K |
Cash from discontinued investing activities | ||
Investing cash flow | 70.43%-263.85K | ---892.15K |
Financing cash flow | ||
Cash flow from continuing financing activities | 4.7M | |
Net common stock issuance | ---- | --4.7M |
Cash from discontinued financing activities | ||
Financing cash flow | ---- | --4.7M |
Net cash flow | ||
Beginning cash position | --3.18M | ---- |
Current changes in cash | -131.28%-995.26K | --3.18M |
Cash adjustments other than cash changes | ---- | --1 |
End cash Position | -31.28%2.19M | --3.18M |
Free cash from | 34.59%-995.26K | ---1.52M |
Accounting Standards | US-GAAP | US-GAAP |
No Data